États-Unis · Plateformes & données · Morningstar

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Publié par Morningstar · États-Unis il y a 18 h

BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing…

Lire l'article complet sur Morningstar Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.morningstar.com)

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

À lire aussi

Amazon’s and Intel’s stocks are set to plunge. But Wall Street’s October winners may surprise you.

Mastech Digital Non-GAAP EPS of $0.10 beats by $0.03, revenue of $41.99M beats by $0.45M

Best Tech Stocks Right Now

Lear stock tumbles 15% on weak revenue outlook

Smarter Braking for Electric Travel Trailers

Amazon shares are tumbling after third-quarter earnings miss. Analysts say buy the dip

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Partager

À lire aussi

Amazon’s and Intel’s stocks are set to plunge. But Wall Street’s October winners may surprise you.

Mastech Digital Non-GAAP EPS of $0.10 beats by $0.03, revenue of $41.99M beats by $0.45M

Best Tech Stocks Right Now

Lear stock tumbles 15% on weak revenue outlook

Smarter Braking for Electric Travel Trailers

Amazon shares are tumbling after third-quarter earnings miss. Analysts say buy the dip